Adenosquamous cell lung cancer
Information
- Disease name
- Adenosquamous cell lung cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01345851 | Active, not recruiting | N/A | Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | March 23, 2011 | January 31, 2026 |
| NCT05292859 | Active, not recruiting | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | October 1, 2022 | June 2039 | |
| NCT05194735 | Active, not recruiting | Phase 1/Phase 2 | Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors | April 4, 2022 | November 30, 2024 |
| NCT00049543 | Completed | Phase 3 | Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | September 2002 | April 2011 |
| NCT00118183 | Completed | Phase 2 | Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | July 2005 | |
| NCT00368992 | Completed | Phase 2 | S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | August 2006 | October 2010 |
| NCT00002852 | Completed | Phase 3 | Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | October 1996 | |
| NCT01557959 | Completed | Phase 2 | Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | July 2007 | February 2011 |
| NCT01958372 | Completed | Phase 1 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | August 2014 | November 11, 2019 |
| NCT00387374 | Completed | Phase 2 | Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab | October 2006 | |
| NCT00005838 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | March 2000 | |
| NCT00040794 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | May 2002 | |
| NCT02264210 | Recruiting | Phase 2 | Icotinib for Completed Resected IB NSCLC With EGFR Mutation | January 2015 | December 2025 |